EX1 0.57% 87.5¢ exopharm limited

Welcome to ASX Exopharm., page-63

  1. 2,452 Posts.
    lightbulb Created with Sketch. 314

    This is really interesting.  Antibiotic resistant bacteria is one of the biggest global healthcare challenges & has become so serious, that Drs are now having to get advice & permission to prescribe courses of certain types of antibiotics in hospitals.  Overuse of antibiotics in the past has been a contributing factor to this problem.  MRSA (“golden staph”) is very common.  

    https://www.dovepress.com/exosome-encapsulated-antibiotic-against-intracellular-infections-of-me-peer-reviewed-fulltext-article-IJN 


    Another indication for Exosomes it seems from this research.  


    This will be interesting especially in relation to wound healing.  GLTAH


 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.